A Chlamydomonas-derived Human Papillomavirus 16 E7 vaccine induces specific tumor protection.

Lane 1, 3 and 4 – colony PCR resulting in a band with the expected size (986pb) for the insert cloned in pET21a 773; Lanes 2 and 5 – colony PCR resulting in bands corresponding

1: A - Randomly amplified polymorphic DNA profiles of individual Schistosoma mansoni LE strain, males (lanes a), females (lanes b) and pairs (lanes c) from three different mice,

A rapid method for simultaneous detection of phenotypic resistance to inhibitors of protease and reverse tran- scriptase in recombinant human immunodeficiency virus type 1 isolates

FIGURE 1 - Representative 1.5% agarose gel showing ampliication products of 120 (lanes 2-6, conserved region with L150/L152 primers), approximately 720 (lanes 7-11, variable

In the present study, we report the immune responses and anti-tumor effects of a DNA vaccine (pgD-E7E6E5) expressing three proteins (E7, E6, and E5) of the human papillomavirus

Number of HIV-positive patients taking protease inhibitors (PI) or non-nucleoside analogue reverse transcriptase inhibitors (NNRTI) in the outpatient clinic of the

Lanes: PM molecular weight (100 bp); C+ positive control (from Psittacula krameri); C- negative control (from chicken liver DNA); Lanes 1, 2, 3, 4 and 5: psittacine field

Lane 1, No enzyme control, lane 2, ds RNA boiled at 95 u C for 5 min to generate a marker for the single- stranded (SS) product. Lanes 3–5 contain wild-type HrpA and lines 6–8,